Both in Pharmaceuticals
Vistagen Therapeutics vs Ensysce Biosciences
Over the past year VTGN returned −95.4% and ENSC returned −75.7%; their daily moves had a correlation of 0.08.
VTGN −95.4% ENSC −75.7%Growth of $1, one year, split-adjusted
| Metric | VTGN | ENSC |
|---|---|---|
| Price | $0.1870 | $0.5110 |
| Market cap | $8.3M | $9.9M |
| Today | −3.41% | −1.73% |
| 1 month | −49.2% | +23.3% |
| 6 months | −67.2% | +20.5% |
| Year to date | −71.7% | −44.5% |
| 1 year | −95.6% | −78.0% |
| Revenue growth (YoY) | +504.9% | −15.1% |
| Gross margin | 100.0% | 100.0% |
| Net margin | −882.8% | −220.8% |
| P/E (TTM) | — | — |
| Price / sales | 3.3× | 2.2× |
| Net cash | $31.7M | $479.9K |
| Dividend yield | — | — |
| Volatility (60d) | 114.8% | 137.3% |
| Short % of float | 8.7% | 7.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).